Zentalis Pharmaceuticals Inc

ZNTL NASDAQ Santé & Biotech États-Unis US98943L1070
3.78 $
0.80 %

Zentalis Pharmaceuticals Inc est engagée dans la recherche et le développement de traitements anti-cancéreux ciblés.

Performance & Momentum

6 Months 173.91 %
1 Year 150.33 %
3 Years 86.31 %
5 Years 92.46 %

Similar stocks to Zentalis Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Zentalis Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases